JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Snyder, E. W.
Right arrow Articles by Schlehuber, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snyder, E. W.
Right arrow Articles by Schlehuber, C.

Naloxone epileptogenesis in monkeys

EW Snyder, RE Dustman and C Schlehuber

The electroencephalographic effects of a range of doses of naloxone were evaluated in an effort to address the apparent epileptogenic properties of the drug. Electrographic activity was recorded from epidural electrodes in eight monkeys. The records were visually inspected and subjected to power spectral analyses. Concurrent visual evoked potentials were recorded and analyzed by standard procedures. Large doses (greater than 32.0 mg/kg i.m.) of naloxone were quickly and reliably succeeded by high voltage electrographic seizure activity at cortex. Lower doses (greater than or equal to 8.0 mg/kg) were followed by increased voltage in high frequency electroencephalogram (EEG) and spiking activity. Visual evoked potential latencies were reliably extended. As determined by power spectral analyses and third order slope analyses, the drug effects on EEG were related to time and dose. The early effects of high doses mimicked the maximal effects of low doses. It is concluded that seizures which follow high doses (48.0-- 64.0 mg/kg) of naloxone are derived from changes which are evident after doses which approach those used clinically to antagonize opiates. Such changes are, however, not readily apparent under visual inspection of the EEG.

Volume 217, Issue 2, pp. 299-305, 05/01/1981
Copyright © 1981 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics.